China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab
The study data showed that compared to chemotherapy alone, toripalimab in combination with chemotherapy in the first-line treatment of patients with advanced NSCLC without EGFR/ALK mutations could significantly improve the PFS and the OS of patients with a manageable safety profile regardless of PD-L1 expression status.
Sep 20, 2022 03:35 PM
Smart IoT Device Brings Future Homes into Focus, but Sparks with Interoperability Issue
With the dawn of home automation having been heralded for years, the 'smart' label of in-home products as forthcoming additions has become ubiquitous in the sustainable technology market. Global companies sought to further underline their credentials in home automation which led to a massive stretch of the imagination from smart light bulbs and thermostats to doorbells.
Jun 02, 2022 10:07 PM
China's Road to Tackle Autoimmune Diseases Globally
Yesterday 08:00 AM
15 Chinese Companies to Watch in September 2022 – New Consumption
Oct 03, 2022 06:17 PM
China VC Investment List Q3 2022 - New Consumption
Oct 02, 2022 12:00 PM
15 Chinese Companies to Watch in August 2022 - Mobility
Sep 30, 2022 10:48 PM